Public Health Europe - European Commission - EU
These Guidelines, prepared by the Scientific Committee on Health, Environmental and Emerging Risks (SCHEER), concern guidance on how to perform benefit-risk assessment of phthalates used in certain medical devices.
The Conference will highlight the results of the current and previous EU Health Programmes and present the new approach in the future Multiannual Financial Framework for 2021-2027. Registration is open. The Conference will be broadcast live the day of the Conference via webstreaming.
In this last newsletter before the summer holiday, European Commission Director of Public Health John F. Ryan briefly discusses how summer impacts public health and the EU measures that keep EU citizens safe, not only during summer holidays, but all year round.
The recognition today by the U.S. Food and Drug Administration (FDA) of Slovakia, the last outstanding EU Member State, marks the full implementation of the EU-U.S. Mutual Recognition Agreement (MRA) for inspections of manufacturing sites for human medicines in their respective territories.